Top compounds associated with response to CLDN3


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.32 2e-15
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.31 2e-12
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.29 2e-11
mRNA TW 37 GDSC1000 pan-cancer AAC -0.26 7e-10
mRNA austocystin d CTRPv2 pan-cancer AAC 0.25 8e-10
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.25 9e-09
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.25 2e-08
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.25 4e-08
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.23 9e-08
mRNA Doxorubicin gCSI pan-cancer AAC -0.34 2e-07
Download CSV